|
PARVA expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.576190E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.617300E-03 |
| Normal-vs-Stage2 |
3.170300E-04 |
| Normal-vs-Stage3 |
1.883770E-02 |
| Normal-vs-Stage4 |
9.894200E-02 |
| Stage1-vs-Stage2 |
9.575600E-02 |
| Stage1-vs-Stage3 |
9.061000E-01 |
| Stage1-vs-Stage4 |
5.996400E-01 |
| Stage2-vs-Stage3 |
1.264630E-01 |
| Stage2-vs-Stage4 |
7.920400E-02 |
| Stage3-vs-Stage4 |
7.089800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.961400E-03 |
| Normal-vs-AfricanAmerican |
6.364000E-01 |
| Normal-vs-Asian |
1.732760E-01 |
| Caucasian-vs-AfricanAmerican |
3.115400E-01 |
| Caucasian-vs-Asian |
5.262400E-01 |
| AfricanAmerican-vs-Asian |
6.293200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.661890E-03 |
| Normal-vs-Female |
4.475300E-03 |
| Male-vs-Female |
2.771400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.223700E-02 |
| Normal-vs-Age(41-60Yrs) |
9.021400E-03 |
| Normal-vs-Age(61-80Yrs) |
3.808300E-04 |
| Normal-vs-Age(81-100Yrs) |
1.412990E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.238200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.762000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.779400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.508170E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.506000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.350200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.776100E-02 |
| Classical-VS-Follicular |
1.59017243817061E-12 |
| Classical-VS-Other |
1.457750E-01 |
| Classical-VS-Normal |
1.465160E-01 |
| Tall-VS-Follicular |
1.57399999700658E-08 |
| Tall-VS-Other |
2.619700E-02 |
| Tall-VS-Normal |
6.363400E-01 |
| Follicular-VS-Other |
3.601800E-01 |
| Follicular-VS-Normal |
3.11280001774605E-10 |
| Other-VS-Normal |
2.696000E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.47679999998418E-06 |
| Normal-vs-N1 |
6.426100E-02 |
| N0-vs-N1 |
6.753700E-02 |
|
|
